2006
DOI: 10.1016/s1359-6446(05)03662-7
|View full text |Cite
|
Sign up to set email alerts
|

Targeting N-type and T-type calcium channels for the treatment of pain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
90
0

Year Published

2007
2007
2017
2017

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 121 publications
(92 citation statements)
references
References 120 publications
2
90
0
Order By: Relevance
“…Loperamide-induced inhibition of voltage-gated calcium channels (Church et al 1994;Hagiwara et al 2003;Reynolds et al 1984) and NMDA receptors (Church et al 1994) present both in CNS and in sensory fibers (Carlton et al 1995;Coggeshall and Carlton 1998;Davidson et al 1997;Kinkelin et al 2000) is broadly consistent with its analgesic properties, considering the well-documented efficacy of selective antagonists of voltage-gated calcium channels and NMDA receptors in treating inflammatory and neuropathic pain symptoms (Chizh and Headley 2005;McGivern 2006). Our finding of loperamide-induced inhibition of HCN channels is also consistent with HCN channels involvement in the pathophysiology of pain (Chaplan et al 2003;Hutcheon and Yarom 2000;Pape 1996;Yao et al 2003).…”
Section: Physiological Significance Of Loperamide-induced I H Inhibitionmentioning
confidence: 95%
“…Loperamide-induced inhibition of voltage-gated calcium channels (Church et al 1994;Hagiwara et al 2003;Reynolds et al 1984) and NMDA receptors (Church et al 1994) present both in CNS and in sensory fibers (Carlton et al 1995;Coggeshall and Carlton 1998;Davidson et al 1997;Kinkelin et al 2000) is broadly consistent with its analgesic properties, considering the well-documented efficacy of selective antagonists of voltage-gated calcium channels and NMDA receptors in treating inflammatory and neuropathic pain symptoms (Chizh and Headley 2005;McGivern 2006). Our finding of loperamide-induced inhibition of HCN channels is also consistent with HCN channels involvement in the pathophysiology of pain (Chaplan et al 2003;Hutcheon and Yarom 2000;Pape 1996;Yao et al 2003).…”
Section: Physiological Significance Of Loperamide-induced I H Inhibitionmentioning
confidence: 95%
“…Ziconotide (Prialt Ò ), an analgesic drug that works by specifically targeting N-type calcium channels, is also approved by several government regulatory bodies worldwide, for the treatment of severe chronic pain associated with cancer, AIDS and neuropathies [11]. Based on the literature and clinical judgment of the pain management physicians, other analgesic agents are known to be infused into the cerebrospinal fluid.…”
mentioning
confidence: 99%
“…In the peripheral nervous system, HVA (including L-, N-, P/Q and R-type) and LVA channels have been identified in TG and DRG neurons (Borgland et al, 2001;Kim and Chung, 1999). In nociceptors, VGCCs contribute to the upstroke and duration of AP and when activated may depolarize the nociceptor and release pro-inflammatory transmitters and peptides therefore, VGCCs are important targets for the treatment of pain (Bourinet and Zamponi, 2005;McGivern, 2006;Wallace, 2000), including acute (Ogasawara et al, 2001), chronic and neuropathic pain (Snutch, 2005). In this study, LVA current was found only in about 7% (54/744) small and medium size TG neurons (data not shown), so we focused our experiment on I HVA .…”
Section: Physiological Significancementioning
confidence: 99%